Healthcare Services Group Inc.
Find Ratings ReportsHEALTHCARE SERVICES GROUP's gross profit margin for the fourth quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. Even though sales decreased, the net income has increased. HEALTHCARE SERVICES GROUP is extremely liquid. Currently, the Quick Ratio is 2.45 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 7.14% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
Income Statement | Q4 FY23 | Q4 FY22 |
---|---|---|
Net Sales ($mil) | 425.0 | 425.02 |
EBITDA ($mil) | 30.25 | 20.84 |
EBIT ($mil) | 28.27 | 18.59 |
Net Income ($mil) | 22.6 | 16.16 |
Balance Sheet | Q4 FY23 | Q4 FY22 |
---|---|---|
Cash & Equiv. ($mil) | 147.46 | 121.48 |
Total Assets ($mil) | 790.65 | 718.33 |
Total Debt ($mil) | 43.64 | 38.4 |
Equity ($mil) | 456.62 | 426.17 |
Profitability | Q4 FY23 | Q4 FY22 |
---|---|---|
Gross Profit Margin | 18.0 | 14.2 |
EBITDA Margin | 7.11 | 4.9 |
Operating Margin | 6.65 | 4.37 |
Sales Turnover | 2.13 | 2.37 |
Return on Assets | 4.85 | 4.82 |
Return on Equity | 8.41 | 8.13 |
Debt | Q4 FY23 | Q4 FY22 |
---|---|---|
Current Ratio | 2.64 | 2.85 |
Debt/Capital | 0.09 | 0.08 |
Interest Expense | 2.06 | 1.24 |
Interest Coverage | 13.74 | 15.05 |
Share Data | Q4 FY23 | Q4 FY22 |
---|---|---|
Shares outstanding (mil) | 73.34 | 74.09 |
Div / share | 0.0 | 0.22 |
EPS | 0.31 | 0.22 |
Book value / share | 6.23 | 5.75 |
Institutional Own % | n/a | n/a |
Avg Daily Volume | 586829.0 | 760418.0 |
HOLD. This stock's P/E ratio indicates a premium compared to an average of 21.06 for the Ambulatory Health Care Services subsector and a discount compared to the S&P 500 average of 27.95. Conducting a second comparison, its price-to-book ratio of 1.95 indicates a significant discount versus the S&P 500 average of 4.68 and a discount versus the subsector average of 3.19. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount.
Price/Earnings |
|
Price/Cash Flow |
| |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCSG 22.87 | Peers 21.06 | HCSG 20.44 | Peers 54.00 | |||||||||||||||||||||
Average. An average P/E ratio can signify an subsector neutral price for a stock and an average growth expectation. HCSG is trading at a valuation on par with its peers. |
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures. HCSG is trading at a significant discount to its peers. |
|||||||||||||||||||||||
Price/Projected Earnings |
|
Price to Earnings/Growth |
|
|||||||||||||||||||||
HCSG 14.09 | Peers 15.17 | HCSG 0.48 | Peers 0.67 | |||||||||||||||||||||
Average. An average price-to-projected earnings ratio can signify an subsector neutral stock price and average future growth expectations. HCSG is trading at a valuation on par with its peers. |
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples. HCSG trades at a significant discount to its peers. |
|||||||||||||||||||||||
Price/Book |
|
Earnings Growth |
|
|||||||||||||||||||||
HCSG 1.95 | Peers 3.19 | HCSG 15.21 | Peers 33.66 | |||||||||||||||||||||
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet. HCSG is trading at a significant discount to its peers. |
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios. However, HCSG is expected to significantly trail its peers on the basis of its earnings growth rate. |
|||||||||||||||||||||||
Price/Sales |
|
Sales Growth |
|
|||||||||||||||||||||
HCSG 0.53 | Peers 1.25 | HCSG -0.89 | Peers 10.95 | |||||||||||||||||||||
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales. HCSG is trading at a significant discount to its subsector on this measurement. |
Lower. A sales growth rate that trails the subsector implies that a company is losing market share. HCSG significantly trails its peers on the basis of sales growth. |
|||||||||||||||||||||||